• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病成年患者对医院疼痛、情绪及健康相关生活质量的自我评估。

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease.

作者信息

Anie Kofi A, Grocott Hannah, White Lauren, Dzingina Mendwas, Rogers Gabriel, Cho Gavin

机构信息

Haematology and Sickle Cell Centre, Central Middlesex Hospital, London, UK.

出版信息

BMJ Open. 2012 Jul 2;2(4). doi: 10.1136/bmjopen-2012-001274. Print 2012.

DOI:10.1136/bmjopen-2012-001274
PMID:22761289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3391376/
Abstract

INTRODUCTION

Acute pain is a hallmark of sickle cell disease (SCD) for which frequent hospital admissions may be required, affecting the quality of life of patients.

OBJECTIVES

To characterise the relationship between adult patient self-reported sickle cell pain, mood and quality of life during and after hospital admissions.

DESIGN

Longitudinal study across three time-points.

SETTING

Secondary care, single specialist sickle cell centre.

PARTICIPANTS

510 adult patients with SCD admitted to hospital daycare or inpatient units.

OUTCOME MEASURES

Self-assessments of pain, mood and health-related quality of life with health utility (measured on the EQ-5D) on admission, before discharge and at 1-week postdischarge.

RESULTS

Mood, general health and quality of life showed significant steady improvements with reduction of pain in patients with SCD on admission to hospital, before discharge and at 1-week follow-up (p<0.01). Health utility scores derived from the EQ-5D showed a negative association with pain in regression analysis over the three time-points.

CONCLUSION

Examining health-related quality of life and health utility in relation to pain during hospital admissions is valuable in terms of targeting appropriate psychological interventions within the context of a multidisciplinary approach to managing sickle cell pain. This has implications for healthcare costs.

摘要

引言

急性疼痛是镰状细胞病(SCD)的一个特征,为此可能需要频繁住院,这会影响患者的生活质量。

目的

描述成年患者自我报告的镰状细胞疼痛、情绪与住院期间及出院后生活质量之间的关系。

设计

在三个时间点进行的纵向研究。

地点

二级医疗,单一专科镰状细胞中心。

参与者

510名入住医院日间护理或住院病房的成年SCD患者。

观察指标

在入院时、出院前和出院后1周,采用健康效用(通过EQ-5D测量)对疼痛、情绪和与健康相关的生活质量进行自我评估。

结果

在入院时、出院前和1周随访时,SCD患者的情绪、总体健康状况和生活质量随着疼痛减轻而显著稳步改善(p<0.01)。在三个时间点的回归分析中,EQ-5D得出的健康效用评分与疼痛呈负相关。

结论

在多学科方法管理镰状细胞疼痛的背景下,研究住院期间与疼痛相关的健康相关生活质量和健康效用,对于确定适当的心理干预措施具有重要价值。这对医疗成本有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/e6f6c060010e/bmjopen-2012-001274fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/0aa9013f2914/bmjopen-2012-001274fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/775bf0c7d45f/bmjopen-2012-001274fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/cc193de55b8c/bmjopen-2012-001274fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/e6f6c060010e/bmjopen-2012-001274fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/0aa9013f2914/bmjopen-2012-001274fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/775bf0c7d45f/bmjopen-2012-001274fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/cc193de55b8c/bmjopen-2012-001274fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c1/3391376/e6f6c060010e/bmjopen-2012-001274fig4.jpg

相似文献

1
Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease.镰状细胞病成年患者对医院疼痛、情绪及健康相关生活质量的自我评估。
BMJ Open. 2012 Jul 2;2(4). doi: 10.1136/bmjopen-2012-001274. Print 2012.
2
Health related quality of life in sickle cell patients: the PiSCES project.镰状细胞病患者的健康相关生活质量:PiSCES项目
Health Qual Life Outcomes. 2005 Aug 29;3:50. doi: 10.1186/1477-7525-3-50.
3
Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.镰状细胞病成人患者的阿片类药物剂量与急性护理利用结果:急诊科与急性护理病房对比
Am J Emerg Med. 2018 Jan;36(1):88-92. doi: 10.1016/j.ajem.2017.07.037. Epub 2017 Jul 13.
4
Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care.镰状细胞病的医疗质量:横断面研究及针对报告门诊和急诊科护理情况的成年人制定一项衡量标准。
Medicine (Baltimore). 2016 Aug;95(35):e4528. doi: 10.1097/MD.0000000000004528.
5
Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.成人急诊患者镰状细胞疼痛危象:改善镇痛管理的学习协作模式。
Acad Emerg Med. 2010 Apr;17(4):399-407. doi: 10.1111/j.1553-2712.2010.00693.x.
6
Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.群组认知行为方案对减轻类风湿关节炎疲劳的影响:RAFT RCT 伴有经济和定性评估。
Health Technol Assess. 2019 Oct;23(57):1-130. doi: 10.3310/hta23570.
7
Can care staff accurately assess health-related quality of life of care home residents? A secondary analysis of data from the OPERA trial.护理人员能否准确评估养老院居民的健康相关生活质量?对OPERA试验数据的二次分析。
BMJ Open. 2017 Apr 27;7(4):e012779. doi: 10.1136/bmjopen-2016-012779.
8
Not being heard: barriers to high quality unplanned hospital care during young people's transition to adult services - evidence from 'this sickle cell life' research.未被倾听:年轻人向成人服务过渡期间高质量非计划性医院护理的障碍 - “这种镰状细胞生活”研究的证据。
BMC Health Serv Res. 2019 Nov 21;19(1):876. doi: 10.1186/s12913-019-4726-5.
9
A Qualitative Study of Chronic Pain and Self-Management in Adults with Sickle Cell Disease.成人镰状细胞病慢性疼痛与自我管理的定性研究。
J Natl Med Assoc. 2019 Apr;111(2):158-168. doi: 10.1016/j.jnma.2018.08.001. Epub 2018 Sep 26.
10
Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care.成人镰状细胞病 (SCD) 患者的医院自行出院:与信任和人际护理体验的关联。
J Hosp Med. 2010 May-Jun;5(5):289-94. doi: 10.1002/jhm.643.

引用本文的文献

1
Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study.英国和法国镰状细胞病患者照顾者的经济负担和生活质量:一项横断面研究。
J Patient Rep Outcomes. 2024 Sep 26;8(1):110. doi: 10.1186/s41687-024-00784-y.
2
Predictors of health-related quality of life in a large cohort of adult patients living with sickle cell disease in France: the DREPAtient study.预测法国大量成年镰状细胞病患者健康相关生活质量的因素:DREPAtient 研究。
Front Public Health. 2024 May 20;12:1374805. doi: 10.3389/fpubh.2024.1374805. eCollection 2024.
3

本文引用的文献

1
The role of stress and mood in sickle cell disease pain: an analysis of daily diary data.压力和情绪在镰状细胞病疼痛中的作用:对日常日记数据的分析。
J Health Psychol. 2000 Jan;5(1):53-63. doi: 10.1177/135910530000500109.
2
Pain management in sickle cell disease: palliative care begins at birth?镰状细胞病的疼痛管理:姑息治疗从出生就开始吗?
Hematology Am Soc Hematol Educ Program. 2008:466-74. doi: 10.1182/asheducation-2008.1.466.
3
Daily assessment of pain in adults with sickle cell disease.镰状细胞病成人患者疼痛的每日评估
Vaso-occlusive crisis pain intensity, frequency, and duration: which best correlates with health-related quality of life in adolescents and adults with sickle cell disease?
血管闭塞性危象的疼痛强度、频率和持续时间:哪一项与镰状细胞病青少年和成人的健康相关生活质量最相关?
Pain. 2024 Jan 1;165(1):135-143. doi: 10.1097/j.pain.0000000000003011. Epub 2023 Aug 11.
4
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States.在美国,增强镰状细胞病公平性的基因疗法的分布成本效益。
Ann Intern Med. 2023 Jun;176(6):779-787. doi: 10.7326/M22-3272. Epub 2023 May 30.
5
[Not Available].[不可用]。
Glob Reg Health Technol Assess. 2021 Apr 2;8:43-52. doi: 10.33393/grhta.2021.2191. eCollection 2021 Jan-Dec.
6
Application of validated mapping algorithms between generic PedsQL scores and utility values to individuals with sickle cell disease.验证后的通用 PedsQL 评分与效用值间映射算法在镰状细胞病个体中的应用。
Qual Life Res. 2022 Sep;31(9):2729-2738. doi: 10.1007/s11136-022-03167-2. Epub 2022 Jun 17.
7
Health State Utilities for Sickle Cell Disease: A Catalog Prepared From a Systematic Review.镰状细胞病健康状态效用值:一项系统评价制定的目录。
Value Health. 2022 Feb;25(2):276-287. doi: 10.1016/j.jval.2021.08.002. Epub 2021 Sep 4.
8
Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease.用于治疗镰状细胞病的假设性细胞或基因疗法的成本效益。
Sci Rep. 2021 May 25;11(1):10838. doi: 10.1038/s41598-021-90405-1.
9
More Unnecessary Imaginary Worlds - Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease.更多不必要的虚构世界 - 第4部分:镰状细胞病的crizanlizumab、voxelotor和L-谷氨酰胺的ICER证据报告
Innov Pharm. 2020 Apr 30;11(2). doi: 10.24926/iip.v11i2.3123. eCollection 2020.
10
Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria.尼日利亚镰状细胞病患者健康相关生活质量的偏好测量及其决定因素。
PLoS One. 2019 Nov 18;14(11):e0223043. doi: 10.1371/journal.pone.0223043. eCollection 2019.
Ann Intern Med. 2008 Jan 15;148(2):94-101. doi: 10.7326/0003-4819-148-2-200801150-00004.
4
Health related quality of life in sickle cell patients: the PiSCES project.镰状细胞病患者的健康相关生活质量:PiSCES项目
Health Qual Life Outcomes. 2005 Aug 29;3:50. doi: 10.1186/1477-7525-3-50.
5
The vital link between chronic disease and depressive disorders.慢性病与抑郁症之间的重要联系。
Prev Chronic Dis. 2005 Jan;2(1):A14. Epub 2004 Dec 15.
6
Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease.日常情绪和压力可预测患有镰状细胞病的非裔美国成年人的疼痛、医疗保健使用情况及工作活动。
Health Psychol. 2004 May;23(3):267-74. doi: 10.1037/0278-6133.23.3.267.
7
Pain, mood and opioid medication use in sickle cell disease.镰状细胞病中的疼痛、情绪与阿片类药物使用
Hematol J. 2003;4(1):71-3. doi: 10.1038/sj.thj.6200227.
8
Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK.镰状细胞病:英国成年人研究中的疼痛、应对方式与生活质量
Br J Health Psychol. 2002 Sep;7(Part 3):331-344. doi: 10.1348/135910702760213715.
9
EuroQol--a new facility for the measurement of health-related quality of life.欧洲生活质量量表——一种衡量健康相关生活质量的新工具。
Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.
10
Sickle cell-related pain: perceptions of medical practitioners.镰状细胞相关疼痛:医学从业者的看法
J Pain Symptom Manage. 1997 Sep;14(3):168-74. doi: 10.1016/S0885-3924(97)00019-5.